Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The term **gin** is non-specific in a pharmacological context and primarily refers to the distilled alcoholic beverage, though it is occasionally used as an abbreviation for **ginseng** (Panax species) in traditional medicine research. As an alcoholic beverage, gin's primary active constituent is ethanol, which acts as a central nervous system (CNS) depressant. Ethanol's mechanism of action involves the positive allosteric modulation of GABA-A receptors and the inhibition of NMDA-type glutamate receptors, leading to sedative and anxiolytic effects. Gin is characterized by its flavor derived from juniper berries (*Juniperus communis*), which contain botanical compounds like alpha-pinene that may possess minor diuretic or antioxidant properties. In the context of herbal medicine, 'gin' may refer to ginseng, which contains ginsenosides that are studied for their adaptogenic effects and modulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gin.